2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow Primary Immunodeficiency: new trials by email Literature Review of Primary Immunodeficiency trials Research Report on Primary Immunodeficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study Rimiducid, rivogenlecleucel - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child | Phase 1 / Phase 2 | Terminated | Bellicum Pharmaceuticals | 187 | 2017-01-01 | 2023-09-26 |
| Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child | Phase 1 / Phase 2 | Terminated | Bellicum Pharmaceuticals | 187 | 2014-04-01 | 2023-09-29 |
Anemia (2) · Anemia, Aplastic (2) · Anemia, Diamond-Blackfan (2) · Anemia, Sickle Cell (2) · Cytopenia (2) · Fanconi Anemia (2) · Hematologic Neoplasms (2) · Hemoglobinopathies (2) · Leukemia (2) · Leukemia, Myeloid, Acute (2) · Lymphoma, Non-Hodgkin (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Primary Immunodeficiency Diseases (2) · Thalassemia (2)
Anemia, Hemolytic (2) · Anemia, Hemolytic, Congenital (2) · Anemia, Hypoplastic, Congenital (2) · Bone Marrow Diseases (2) · Bone Marrow Failure Disorders (2) · Congenital Bone Marrow Failure Syndromes (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · DNA Repair-Deficiency Disorders (2) · Genetic Diseases, Inborn (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Immunoproliferative Disorders (2) · Leukemia, Lymphoid (2)
AP 1903 reagent (2)
Italy (2) · United Kingdom (1)